Accès gratuit
Numéro
Med Sci (Paris)
Volume 21, Numéro 8-9, Août–Septembre 2005
Page(s) 741 - 746
Section M/S revues
DOI https://doi.org/10.1051/medsci/2005218-9741
Publié en ligne 15 août 2005
  1. O’Dowd BF, Heiber M, Chan A, et al. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 1993; 136 : 355–60.
  2. Devic E, Rizzoti K, Bodin S, et al. Amino acid sequence and embryonic expression of msr/apj, the mouse homolog of Xenopus X-msr and human APJ. Mech Dev 1999; 84 : 199–203.
  3. O’Carroll A, Selby TL, Palkovits M, et al. Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochim Biophys Acta 2000; 1492 : 72–80.
  4. De Mota N, Lenkei Z, Llorens-Cortes C. Cloning, pharmacological characterization and brain distribution of the rat apelin receptor. Neuroendocrinology 2000; 72 : 400–7.
  5. Tatemoto K, Hosoya M, Habata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998; 251 : 471–6.
  6. Habata Y, Fujii R, Hosoya M, et al. Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. Biochim Biophys Acta 1999; 13 : 25–35.
  7. Lee DK, Cheng R, Nguyen T, et al. Characterization of apelin, the ligand for the APJ receptor. J Neurochem 2000; 74 : 34–41.
  8. De Mota N, Reaux-Le Goazigo A, El Messari S, et al. Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc Natl Acad Sci USA 2004; 101 : 10464–9.
  9. Kawamata Y, Habata Y, Fukusumi S, et al. Molecular properties of apelin : tissue distribution and receptor binding. Biochim Biophys Acta 2001; 1538 : 162–71.
  10. Zou MX, Liu HY, Haraguchi Y, et al. Apelin peptides block the entry of human immunodeficiency virus (HIV). FEBS Lett 2000; 473 : 15–8.
  11. Medhurst AD, Jennings CA, Robbins MJ, et al. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J Neurochem 2003; 84 : 1162–72.
  12. Reaux A, De Mota N, Skultetyova I, et al. Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem 2001; 77 :1085–96.
  13. El Messari S, Iturrioz X, Fassot C, et al. Functional dissociation of apelin receptor signaling and endocytosis : implications for the effects of apelin on arterial blood pressure. J Neurochem 2004; 90 : 1290–301.
  14. Masri B, Morin N, Cornu M, et al. Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells. FASEB J 2004; 18 : 1909–11.
  15. Reaux A, Gallatz K, Palkovits M, Llorens-Cortes C. Distribution of apelin-synthesizing neurons in the adult rat brain. Neuroscience 2002; 113 : 653–62.
  16. Brailoiu, GC, Dun SL, Yang J, et al. Apelin-immunoreactivity in the rat hypothalamus and pituitary. Neurosci Lett 2002; 327 : 193–7.
  17. Reaux-Le Goazigo A, Morinville A, Burlet A, et al. Dehydration-induced cross regulation of apelin and vasopressin immunoreactivity levels in magnocellular hypothalamic neurons. Endocrinology 2004; 145 : 4392–400.
  18. Johnson AK, Cunningham JT, Thunhorst RL. Integrative role of the lamina terminalis in the regulation of cardiovascular and body fluid homeostasis. Clin Exp Pharmacol Physiol 1996; 23 : 183–91.
  19. O’Carroll AM, Lolait SJ. Regulation of rat APJ receptor messenger ribonucleic acid expression in magnocellular neurones of the paraventricular and supraoptic nuclei by osmotic stimuli. J Neuroendocrinol 2003; 15 : 661–6.
  20. Hurbin A, Boissin-Agasse L, Orcel H, et al. The V1a and V1b, but not V2, vasopressin receptor genes are expressed in the supraoptic nucleus of the rat hypothalamus, and the transcripts are essentially colocalized in the vasopressinergic magnocellular neurons. Endocrinology 1998; 139 : 4701–7.
  21. Brownstein MJ, Russell JT, Gainer H. Synthesis, transport, and release of posterior pituitary hormones. Science 1980; 207 : 373–8.
  22. Manning M, Lowbridge J, Haldar J, et al. Design of neurohypophyseal peptides that exhibit selective agonistic and antagonistic properties. Fed Proc 1977; 36 : 1848–52.
  23. Zini S, Fournie-Zaluski MC, Chauvel E, et al. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors : predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci USA 1996; 93 : 11968–73.
  24. Gutkowska J, Antunes-Rodrigues J, McCann SM. Atrial natriuretic peptide in brain and pituitary gland. Physiol Rev 1997; 77 : 465–515.
  25. Poulain DA, Wakerley JB, Dyball RE. Electrophysiological differentiation of oxytocin- and vasopressin-secreting neurones. Proc R Soc Lond B Biol Sci 1977; 196 : 367–84.
  26. Gouzenes L, Desarmenien MG, Hussy N, et al. Vasopressin regularizes the phasic firing pattern of rat hypothalamic magnocellular vasopressin neurons. J Neurosci 1998; 18 : 1879–85.
  27. Ludwig M. Dendritic release of vasopressin and oxytocin. J Neuroendocrinol 1998; 10 : 881–95.
  28. Hosoya M, Kawamata Y, Fukusumi S et al. Molecular and functional characteristics of APJ : tissue distribution of mRNA and interaction with endogenous ligand, apelin. J Biol Chem 2000; 275 : 21061–7.
  29. De Falco M, De Luca L, Onori N, et al. Apelin expression in normal human tissues. In Vivo 2002; 16 : 333–6.
  30. Denton DA, McKinley MJ, Weisinger RS. Hypothalamic integration of body fluid regulation. Proc Natl Acad Sci USA 1996; 93 : 7397–404.
  31. Tatemoto K, Takayama K, Zou MX, et al. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 2001; 99 : 87–92.
  32. Szokodi I, Tavi P, Foldes G, et al. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 2002; 91 : 434–40.
  33. Chen MM, Ashley EA, Deng DX, et al. Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction. Circulation 2003; 108 : 1432–9.
  34. Berry MF, Pirolli TJ, Jayasankar V, et al. Apelin has in vivo inotropic effects on normal and failing hearts. Circulation 2004; 110 : II187–93.
  35. Ashley EA, Powers J, Chen M, et al. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovascular Res 2005; 65 :73–82.
  36. Földes G, Horkay F, Szokodi I, et al. Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochem Biophys Res Commun 2003; 308 : 480–5.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.